Literature DB >> 284363

Modification of the blood-brain barrier: increased concentration and fate of enzymes entering the brain.

J A Barranger, S I Rapoport, W R Fredericks, P G Pentchev, K D MacDermot, J K Steusing, R O Brady.   

Abstract

The blood-brain barrier of rats was opened reversibly by infusing a hyperosmotic solution of arabinose into the external carotid artery. Permeability was increased maximally in the first 15 min and remained slightly elevated at 1 hr. Osmotic barrier opening significantly increased brain uptake of intravenously injected alpha-mannosidase (alpha-D-mannoside mannohydrolase, EC 3.2.1.2.4) (derived from human placenta) and horseradish peroxidase (donor:hydrogen-peroxide oxidoreductase, EC 1.11.1.7). By injection of 4 X 10(5) units of alpha-mannosidase into an animal, brain activity rose to about twice the normal control activity of the enzyme. After 30 min, activity of administered enzyme in the extracellular space of the brain was calculated to be 30% of the serum concentration. Biochemical and histological studies with horseradish peroxidase showed that exogenously administered enzyme entered the brain extracellular space immediately after barrier opening and was incorporated within neuronal lysosomal packets during the next 24 hr. Measurable peroxidase activity was found in brain as much as 72 hr after osmotic treatment. The results demonstrate that the blood-brain barrier can be reversibly opened to enzymes, that a glycoprotein enzyme is incorporated into neuronal lysosomes, and that the brain may now be considered a potential target for enzyme replacement therapy in heritable metabolic disorders.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 284363      PMCID: PMC382965          DOI: 10.1073/pnas.76.1.481

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  SERUM LACTIC DEHYDROGENASE ACTIVITY: AN ANALYTICAL ASSESSMENT OF CURRENT ASSAYS.

Authors:  E AMADOR; L E DORFMAN; W E WACKER
Journal:  Clin Chem       Date:  1963-08       Impact factor: 8.327

2.  Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue.

Authors:  C DE DUVE; B C PRESSMAN; R GIANETTO; R WATTIAUX; F APPELMANS
Journal:  Biochem J       Date:  1955-08       Impact factor: 3.857

3.  Evidence for receptor-mediated binding of glycoproteins, glycoconjugates, and lysosomal glycosidases by alveolar macrophages.

Authors:  P D Stahl; J S Rodman; M J Miller; P H Schlesinger
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

4.  Inhibition of the rat clearance system for agalacto-orosomucoid by yeast mannans and by mannose.

Authors:  D T Achord; F E Brot; W S Sly
Journal:  Biochem Biophys Res Commun       Date:  1977-07-11       Impact factor: 3.575

5.  Entry of neutralizing antibody to measles into brain and cerebrospinal fluid of immunized monkeys after osmotic opening of the blood-brain barrier.

Authors:  J T Hicks; P Albrecht; S I Rapoport
Journal:  Exp Neurol       Date:  1976-12       Impact factor: 5.330

6.  Regional cerebrovascular permeability to [14C]sucrose after osmotic opening of the blood-brain barrier.

Authors:  S I Rapoport; K Ohno; W R Fredericks; K D Pettigrew
Journal:  Brain Res       Date:  1978-07-21       Impact factor: 3.252

7.  Anterograde transport of horseradish peroxidase enhanced by poly-L-ornithine.

Authors:  S K Itaya; T H Williams; E L Engel
Journal:  Brain Res       Date:  1978-07-07       Impact factor: 3.252

8.  Reversible osmotic opening of the blood-brain barrier.

Authors:  S I Rapoport; M Hori; I Klatzo
Journal:  Science       Date:  1971-09-10       Impact factor: 47.728

9.  Enzyme replacement therapy in Gaucher's disease: large-scale purification of glucocerebrosidase suitable for human administration.

Authors:  F S Furbish; H E Blair; J Shiloach; P G Pentchev; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

10.  Entry of [3H]norepinephrine, [125I]albumin and Evans blue from blood into brain following unilateral osmotic opening of the blood-brain barrier.

Authors:  C C Chiueh; C L Sun; I J Kopin; W R Fredericks; S I Rapoport
Journal:  Brain Res       Date:  1978-04-28       Impact factor: 3.252

View more
  16 in total

Review 1.  Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications.

Authors:  S I Rapoport
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

Review 2.  The clinical management of Type 2 Gaucher disease.

Authors:  Karin Weiss; Ashley Gonzalez; Grisel Lopez; Leah Pedoeim; Catherine Groden; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2014-11-14       Impact factor: 4.797

Review 3.  An innovative approach to the treatment of Gaucher disease and possibly other metabolic disorders of the brain.

Authors:  Roscoe O Brady; Chunzhang Yang; Zhengping Zhuang
Journal:  J Inherit Metab Dis       Date:  2012-07-20       Impact factor: 4.982

4.  Impact of drug size on brain tumor and brain parenchyma delivery after a blood-brain barrier disruption.

Authors:  Marie Blanchette; Luc Tremblay; Martin Lepage; David Fortin
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-12       Impact factor: 6.200

Review 5.  Drug transport across the blood-brain barrier. III. Mechanisms and methods to improve drug delivery to the central nervous system.

Authors:  J B Van Bree; A G De Boer; M Danhof; D D Breimer
Journal:  Pharm World Sci       Date:  1993-02-19

6.  Insulin fragments as a carrier for peptide delivery across the blood-brain barrier.

Authors:  M Fukuta; H Okada; S Iinuma; S Yanai; H Toguchi
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

7.  Capillary junctions of the rat are not affected by osmotic opening of the blood-brain barrier.

Authors:  C L Farrell; R R Shivers
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

8.  Delivery, distribution, and neuronal uptake of exogenous mannose-terminal glucocerebrosidase in the intact rat brain.

Authors:  G C Zirzow; O A Sanchez; G J Murray; R O Brady; E H Oldfield
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

9.  A clinical trial of fibroblast transplantation for the treatment of mucopolysaccharidoses.

Authors:  D A Gibbs; E Spellacy; R Tompkins; R W Watts; J F Mowbray
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

10.  Studies on the permeability of the blood-brain barrier in experimental diabetes.

Authors:  M Lorenzi; D P Healy; R Hawkins; J M Printz; M P Printz
Journal:  Diabetologia       Date:  1986-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.